Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 3, 2008

Drug Name Review Type Class Manufacturer
Alvesco New Drug Initial Review Inhaled Steroids Sepracor
Keppra XR New Drug Initial Review Anticonvulsants UCB
Venlafaxine ER New Drug Initial Review Antidepressants � Other Upstate
Pataday New Drug Initial Review Ophthalmics- Allergic Conjunctivitis Alcon
Factive New Drug Appeal Quinolones Oscient
Patanase New Drug Appeal Nasal Preparations � Other Alcon